Prague Med. Rep. 2017, 118, 69-80
https://doi.org/10.14712/23362936.2017.6
Budd-Chiari Syndrome
References
1. 2017) Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome. Thromb. Haemost. 117, 794–800.
< , W., Dentali, F., Pomero, F., Fenoglio, L., Squizzato, A., Pagani, G., Re, R., Bonzini, M. (https://doi.org/10.1160/TH16-10-0781>
2. 2007) Budd-Chiari syndrome: Etiology, pathogenesis and diagnosis. World J. Gastroenterol. 13, 2693–2696.
< , M., Bayraktar, Y. (https://doi.org/10.3748/wjg.v13.i19.2693>
<PubMed>
3. 2006) Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis. Blood 108, 3223–3224.
< , M., Lippert, E., Girodon, F., Dobo, I., Fouassier, M., Masliah, C., Praloran, V., Hermouet, S. (https://doi.org/10.1182/blood-2006-05-021527>
4. 1991) Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology 100, 1324–1331.
< , L., Gaiani, S., Li Bassi, S., Zironi, G., Bonino, F., Brunetto, M., Barbara, L. (https://doi.org/10.1016/0016-5085(91)90785-J>
5. 2003) Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 37, 510–519.
< , D., Vilgrain, V., Genin, P., Denninger, M.-H., Durand, F., Belghiti, J., Valla, D., Degott, C. (https://doi.org/10.1053/jhep.2003.50076>
6. 2008) Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome. Blood Coagul. Fibrinolysis 19, 459–462.
< , D., Amitrano, L., Tiscia, G. L., Iannaccone, L., Gallone, A., Grandone, E., Guardascione, M. A., Margaglione, M. (https://doi.org/10.1097/MBC.0b013e3283049662>
7. 2009) Vascular disorders of the liver. Hepatology 49, 1729–1764.
< , L. D., Valla, D.-C., Garcia-Tsao, G., American Association for the Study Liver Diseases (https://doi.org/10.1002/hep.22772>
<PubMed>
8. 2016) Diagnosis, etiology and management of the Budd-Chiari syndrome: A bloodcoagulation and hepatological study on the course of the disease treated with TIPS. Int. Angiol. 35, 90–97.
, P., Hůlek, P., Krajina, A., Renc, O., Šafka, V., Fejfar, T., Sadílek, P., Beránek, M., Michiels, J. J., Žák, P. (
9. 2006) Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 55, 878–884.
< , C. E., Velissaris, D., Heydtmann, M., Gunson, B., Olliff, S., Elias, E. (https://doi.org/10.1136/gut.2005.071423>
<PubMed>
10. EASL (2016) EASL Clinical Practice Guidelines: Vascular diseases of the liver. J. Hepatol. 64, 179–202.
11. 2011) Necessity and indications of invasive treatment for Budd-Chiari syndrome. Hepatobiliary Pancreat. Dis. Int. 10, 254–260.
< , Y., Sun, Y.-L., Ma, X.-X., Xu, P.-Q., Feng, L.-S., Tang, Z., Guan, S., Wang, Z.-W., Luo, C.-H. (https://doi.org/10.1016/S1499-3872(11)60042-8>
12. 2008) TIPS for Budd-Chiari syndrome: Long-term results and prognostics factors in 124 patients. Gastroenterology 135, 808–815.
< , J. C., Heydtmann, M., Raffa, S., Plessier, A., Murad, S., Fabris, F., Vizzini, G., Abraldes, J. G., Olliff, S., Nicolini, A., Luca, A., Primignani, M., Janssen, H. L. A., Valla, D., Elias, E., Bosch, J. (https://doi.org/10.1053/j.gastro.2008.05.051>
13. 1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106, 1042–1047.
< , A., Poliquin, M., Vilgrain, V., Belghiti, J., Degott, C., Erlinger, S., Benhamou, J. P. (https://doi.org/10.1016/0016-5085(94)90765-X>
14. 2013) Percutaneous recanalization for Budd-Chiari syndrome: An 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 266, 657–667.
< , G., Qi, X., Zhang, W., He, C., Yin, Z., Wang, J., Xia, J., Xu, K., Guo, W., Niu, J., Wu, K., Fan, D. (https://doi.org/10.1148/radiol.12120856>
15. 2013) The Budd-Chiari syndrome. Tunis. Med. 91, 376–381.
, R., Cheikh, M., Marsaoui, L., Ennaifer, R., Romdhane, H., Nejma, H. B. (
16. 2004) PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40, 1197–1202.
< , M., Turnes, J., Rubinstein, P., Olliff, S., Elias, E., Bosch, J., García-Pagán, J. C. (https://doi.org/10.1002/hep.20436>
17. 2003) Budd-Chiari syndrome: a review by an expert panel. J. Hepatol. 38, 364–371.
< , H. L. A., Garcia-Pagan, J.-C., Elias, E., Mentha, G., Hadengue, A., Valla, D.-C. (https://doi.org/10.1016/S0168-8278(02)00434-8>
18. Lambert, L. (2016) Types of Budd-Chiari syndrome. In: Classifications, Online Calculators, and Tables in Radiology. Available at: http://radclass.mudr.org/content/types-budd-chiari-syndrome (accessed September 30, 2016)
19. 2003) Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J. Hepatol. 39, 496–501.
< , P., Escolano, S., Valla, D., Coste-Zeitoun, D., Denie, C., Mallet, A., Levy, V.-G., Franco, D., Vinel, J.-P., Belghiti, J., Lebrec, D., Hay, J.-M., Zeitoun, G. (https://doi.org/10.1016/S0168-8278(03)00323-4>
20. 2011) Budd-Chiari syndrome management: lights and shadows. World J. Hepatol. 3, 262–264.
< , A. (https://doi.org/10.4254/wjh.v3.i10.262>
<PubMed>
21. 2004) The Budd-Chiari syndrome. N. Engl. J. Med. 350, 578–585.
< , K. V. N., Shah, V., Kamath, P. S. (https://doi.org/10.1056/NEJMra020282>
22. 2011) Imaging and interventions in Budd-Chiari syndrome. World J. Radiol. 3, 169–177.
< , A., Gamanagatti, S. (https://doi.org/10.4329/wjr.v3.i7.169>
<PubMed>
23. 2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39, 500–508.
< , S. D., Valla, D.-C., de Groen, P. C., Zeitoun, G., Hopmans, J. A. M., Haagsma, E. B., van Hoek, B., Hansen, B. E., Rosendaal, F. R., Janssen, H. L. A. (https://doi.org/10.1002/hep.20064>
24. 1998) Proposal of a new nomenclature for Budd-Chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28, 1191–1198.
< , K., Kage, M., Shrestha, S. M. (https://doi.org/10.1002/hep.510280505>
25. 2003) Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur. Radiol. 13, 286–293.
, J.-P., Denys, A., Valla, D., Sibert, A., Sauvanet, A., Belghiti, J., Menu, Y. (
26. 2008) Budd-Chiari syndrome. Semin. Liver Dis. 28, 259–269.
< , A., Valla, D.-C. (https://doi.org/10.1055/s-0028-1085094>
27. 2009) Prognostic indices for Budd-Chiari syndrome: Valid for clinical studies but insufficient for individual management. Am. J. Gastroenterol. 104, 1140–1146.
< , P.-E., Moucari, R., Escolano, S., Cazals-Hatem, D., Denié, C., Chagneau-Derrode, C., Charpignon, C., de Lédinghen, V., Grenouillet-Delacre, M., Habersetzer, F., Nousbaum, J.-B., Denninger, M.-H., Valla, D. C., Plessier, A. (https://doi.org/10.1038/ajg.2009.63>
28. 2013) Long-term patency of transjugular intrahepatic portosystemic shunt (TIPS) in patients with hepatic vein thrombosis. Cesk. Radiol. 67, 109–120. (in Czech).
, O., Krajina, A., Hůlek, P., Lojík, M., Raupach, J., Chovanec, V., Jirkovský, V., Fejfar, T., Šafka, V., Pozler, O., Dulíček, P., Čermáková, E., Machová, V. (
29. 2013) Treatment of Budd-Chiari syndrome with inferior vena cava thrombosis. Exp. Ther. Med. 5, 1254–1258.
, W., Qingyi, M., Lifeng, Q., Xuejun, W., Nianfeng, S., Xing, J. (
30. 2005) Budd-Chiari syndrome and TIPS – twelve years’ experience. Cas. Lek. Cesk. 144, 38–42 (Suppl. 3). (in Czech).
, V., Hůlek, P., Krajina, A., Dulíček, P., Fejfar, T., Jirkovský, V., Pozler, O., Vaňásek, T. (
31. 2005) Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 182–190.
< , M., Cholongitas, E. C., Patch, D., Burroughs, A. K. (https://doi.org/10.1038/ncpgasthep0143>
32. 2004) Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J. Hepatol. 40, 172–180.
< , S., Texeira, A., Texeira, P., Elias, E., Wilde, J., Olliff, S. P. (https://doi.org/10.1016/j.jhep.2003.09.028>
33. 2000) Budd-Chiari syndrome: our experience of 71 patients. J. Gastroenterol. Hepatol. 15, 550–554.
< , V., Sinha, S. K., Nain, C. K., Bambery, P., Kaur, U., Verma, S., Chawla, Y. K., Singh, K. (https://doi.org/10.1046/j.1440-1746.2000.02157.x>
34. 2003) The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 38, 793–803.
< , D.-C. (https://doi.org/10.1002/hep.1840380404>
35. 2004) Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J. Gastroenterol. Hepatol. 19, S204–S211.
< , D.-C. (https://doi.org/10.1111/j.1440-1746.2004.03642.x>
36. 2006) Prognosis in Budd Chiari syndrome after re‐establishing hepatic venous drainage. Gut 55, 761–763.
< , D.-C. (https://doi.org/10.1136/gut.2005.078048>
<PubMed>
37. 2009) Primary Budd-Chiari syndrome. J. Hepatol. 50, 195–203.
< , D.-C. (https://doi.org/10.1016/j.jhep.2008.10.007>
38. 1996) Budd-Chiari syndrome. Curr. Probl. Surg. 33, 81–211.
< , Z. G., Jones, R. S. (https://doi.org/10.1016/S0011-3840(96)80001-3>
39. 2005) Evolution of management for Budd-Chiari syndrome: a team’s view from 2564 patients. ANZ J. Surg. 75, 55–63.
< , Z. G., Zhang, F. J., Yi, M. Q., Qiang, L. X. (https://doi.org/10.1111/j.1445-2197.2005.03135.x>
40. 2007) Medical progress: Etiology, treatment, and classification of Budd·Chiari syndrome. Chin. Med. J. 120, 159–191.
, X., Li, Q. (
41. 2014) Initial imaging analysis of Budd-Chiari syndrome in Henan Province of China: Most cases have combined inferior vena cava and hepatic veins involvement. PLoS One 9, e85135.
< , P., Ren, J., Han, X., Wu, G., Zhang, W., Ding, P., Bi, Y. (https://doi.org/10.1371/journal.pone.0085135>
<PubMed>